CSF3R mutations resulting in the production of truncated G-CSFR proteins that lack from one to four phospho-tyrosine residues and exhibit defective receptor internalization were reported in a majority of CN patients with overt AML or MDS [3–9]. The gene discussed is CSF3R; the disease is myelodysplastic syndrome.